Contents
There is currently no connection between known blood clots and the administration of the COVID-19 vaccine by Johnson & Johnson, the US Food and Drug Administration (FDA) said just days ago. Today, the agency and the CDC called for an immediate discontinuation of the preparation. The reason is six cases of blood clots in women.
- Six cases of bleeding disorders have been reported in the US following the administration of the COVID-19 vaccine from Johnson & Johnson
- FDA and CDC: we recommend discontinuing use of this vaccine out of extreme caution (…) At the moment these adverse events appear to be extremely rare
- Both institutions and scientists to investigate possible links between the J&J COVID-19 vaccine and bleeding disorders
- You can find more up-to-date information on vaccinations against COVID-19 on the Onet homepage.
Cases of coagulation disorders following administration of the J&J vaccine
“The FDA is aware of information in the United States of serious thromboembolic events, sometimes related to thrombocytopenia, that have occurred in several people after receiving the COVID-19 vaccine from Johnson & Johnson,” the announcement said on April 9. “We have not found a causal link with vaccinations at the moment, but we are continuing our investigation and evaluation of these cases,” added (more on this statement).
Today, just four days later, the agency, along with the Centers for Disease Control (CDC, a leading global organization fighting epidemics), are calling for an immediate halt in the use of the Johnson & Johnson coronavirus vaccine. According to The New York Times, the reason is six cases of rare coagulation disorders, which developed about two weeks after the administration of the preparation. They all occurred in women (aged 18 to 48).
To date, nearly seven million people in the US have received the COVID-19 J&J vaccine.
- Thrombosis – causes, treatment and prevention. The six most common symptoms of thrombosis [EXPLAIN]
FDA and CDC: J&J Vaccination Suspension Out Of Caution
— We recommend that you discontinue use of this vaccine out of caution, said Dr. Peter Marks, director of the FDA’s Center for Biological Assessment and Research, and Dr. Anne Schuchat, CDC chief deputy director in a joint statement. – At the moment, these adverse events seem to be extremely rare – they emphasize.
While the FDA and CDC position is formulated as a recommendation to physicians, it is expected that administration of the vaccine will be withheld at all federal immunization centers and that state health services will do the same.
Scientists, together with the FDA and CDC, will investigate possible links between the J&J COVID-19 vaccine and bleeding disorders. They will also determine whether the FDA should continue to allow the vaccine to be used in all adults or whether restrictions are needed.
Recall that on April 9, the European Medicines Agency (EMA) announced that it had started a study of blood clots in people who received the COVID-19 vaccine from Johnson & Johnson. At that time, there were talk of four reported cases.
Johnson & Johnson’s vaccine is currently only used in the US. The preparation was authorized in the EU on March 11, 2021, but vaccination with its use has not yet started.
You may be interested in:
- Are there groups of patients who should not be vaccinated with AstraZeneca?
- AstraZenecę vaccinations safe in inflammatory diseases of the joints? The Polish Society of Rheumatologists responds
- How do I deal with the side effects of vaccination? [WE EXPLAIN]
The content of the medTvoiLokony website is intended to improve, not replace, the contact between the Website User and their doctor. The website is intended for informational and educational purposes only. Before following the specialist knowledge, in particular medical advice, contained on our Website, you must consult a doctor. The Administrator does not bear any consequences resulting from the use of information contained on the Website. Do you need a medical consultation or an e-prescription? Go to halodoctor.pl, where you will get online help – quickly, safely and without leaving your home.Now you can use e-consultation also free of charge under the National Health Fund.